Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Prospective, Double-blind, Placebo-controlled, Randomized Study of the Feasibility of Using the Dietary Supplement "ARTNEO®", Capsules for Oral Administration in Patients With Stage II-III Primary Knee Osteoarthritis

NCT05975879 is registered in ClinicalTrials.gov with NPO Petrovax as lead sponsor.

NCT NCT05975879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05975879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Prospective, Double-blind, Placebo-controlled, Randomized Study of the Feasibility of Using the Dietary Supplement "ARTNEO®", Capsules for Oral Administration in Patients With Stage II-III Primary Knee Osteoarthritis
Lead sponsor
NPO Petrovax
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2022
Completion date
April 17, 2023
Enrollment
212 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

knee arthritis, knee discomfort, knee osteoarthritis, knee pain chronic, knee pain swelling, osteoarthritis, osteoarthritis, knee